Inventor · disambiguated record
Laura Ensign
Also filed as: ENSIGN LAURA · ENSIGN LAURA M
20 granted patents·17 pending applications·118 citations·filing 2011–2023
94Inventor score
Top patents by PatentIndex Score
37 records- 0198US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0294US9415020B2Nanoparticle formulations with enhanced mucosal penetrationUNIV JOHNS HOPKINS·Filed 2013·Granted Aug 16, 2016·27 cites·21 claims
- 0392US10092509B2Hypotonic microbicidal formulations and methods of useUNIV JOHNS HOPKINS·Filed 2015·Granted Oct 9, 2018·8 cites·17 claims
- 0490US12178920B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Dec 31, 2024·0 cites·15 claims
- 0590US10058511B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 28, 2018·2 cites·40 claims
- 0690US9629813B2Nanoparticle formulations with enhanced mucosal penetrationUNIV JOHNS HOPKINS·Filed 2016·Granted Apr 25, 2017·9 cites·20 claims
- 0789US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 0887US11872318B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Jan 16, 2024·0 cites·22 claims
- 0987US11642317B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2020·Granted May 9, 2023·1 cites·31 claims
- 1085US11426345B2Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfacesUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 30, 2022·1 cites·16 claims
- 1184US9737491B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 22, 2017·1 cites·21 claims
- 1283US11633350B2Hypotonic microbicidal formulations and methods of useUNIV JOHNS HOPKINS·Filed 2019·Granted Apr 25, 2023·1 cites·17 claims
- 1383US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 1481US2023190656A1Compositions and methods relating to reduced mucoadhesionUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1580US10485757B2Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfacesUNIV JOHNS HOPKINS·Filed 2016·Granted Nov 26, 2019·2 cites·20 claims
- 1679US10736854B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 11, 2020·2 cites·37 claims
- 1777US2023074691A1Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfacesUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1876US10668025B2Mucus penetrating particles with high molecular weight and dense coatingsUNIV JOHNS HOPKINS·Filed 2016·Granted Jun 2, 2020·4 cites·16 claims
- 1974US2023310311A1Hypotonic microbicidal formulations and methods of useUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 2072US10398742B2CVS transplantation for treatment of bacterial vaginosisUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 3, 2019·1 cites·8 claims
- 2168US10646434B2Hypotonic microbicidal formulations and methods of useUNIV JOHNS HOPKINS·Filed 2018·Granted May 12, 2020·0 cites·16 claims
- 2267US9393212B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·0 cites·31 claims
- 2365US2020078304A1Compositions and methods relating to reduced mucoadhesionUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 2463US2025222119A1Engineering of multifunctional peptides for controlled drug deliveryUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 2563US2025177291A1Hypotonic gel-forming formulations with enhanced rheological propertiesUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2661US2024189277A1Ophthalmic formulations for sustained neuroprotectionUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2760US12005089B2CVS transplantation for treatment of bacterial vaginosisUNIV JOHNS HOPKINS·Filed 2016·Granted Jun 11, 2024·0 cites·11 claims
- 2860US2019015349A1Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel diseaseUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 2960US2020306202A1Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel diseaseUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 3060US2013236556A1Compositions and methods relating to reduced mucoadhesionUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 3157US2021196837A1Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfacesUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3257US2012121718A1Compositions and methods relating to reduced mucoadhesionLAI SAMUEL K·Filed 2011·Application pending·0 cites
- 3356US2017007542A1Compositions and methods relating to reduced mucoadhesionUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 3456US2024374657A1Inflammatory Respiratory Conditions and Treatments ThereofZEPHYRUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3555US2023081539A1Suprachoroidal delivery of drug particles to reduce toxicityUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3646US2021177751A1Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfacesUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 3745US2020009068A1Nanoparticle formulations for enhanced drug delivery to the bladderUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →